Prelude Therapeutics Incorporat

Q1 2022 13F Holders

Symbol
PRLD
CUSIP
74065P101
Type
Equity
Class
COM
Num filers
70
Total reported value, excl. options
$235M
Manager Report Date Value ($000) Shares